Guías Clínicas
101
Guías tam izaje, d iagn óstico y tratam ien to de l hepa toca rcinoma - Sociedad Chilena de Gastroenterología
129.- Vitale A, Morales RR, Zanus G,
Farinati F, Burra P, Angeli P, et al.
Barcelona Clinic Liver Cancer Staging
and Transplant Survival Benefit for
Patients with Hepatocellular Carcinoma:
a Multicentre, Cohort Study. Lancet
Oncol. 2011;12:654-62.
130.- Lei J, Wang W, Yan L. Hangzhou
Criteria for Liver Transplantation in
Hepatocellular Carcinoma: a Single-
Center Experience European. Eur J
Gastroenterol Hepatol. 2014;26:200-4.
131.- Mazzaferro V, Sposito C, Zhou J,
Pinna AD, Carlis L De, Fan J, et al.
Metroticket 2.0 Model for Analysis of
Competing Risks of Death After Liver
Transplantation for Hepatocellular
Carcinoma. Gastroenterology.
2018;154:128-39.
132.- Metroticket Project - Liver
Transplantation for CHC, Individualized
Prognosis Calculators.
133.- Shah S, Cleary S, Wei A, Yang I, Taylor
B, Hemming A, et al. Recurrence After
Liver Resection for Hepatocellular
Carcinoma: Risk Factors, Treatment, and
Outcomes. Surgery. 2007;141:330-9.
134.- Sumie S, Nakashima O, Okuda
K, Kuromatsu R, Kawaguchi A.
The Significance of Classifying
Microvascular Invasion in Patients with
Hepatocellular Carcinoma. Ann Surg
Oncol. 2014;21:1002-9.
135.- Sumie S, Kuromatsu R, Okuda K,
Ando E, Takata A, Fukushima N, et
al. Microvascular Invasion in Patients
with Hepatocellular Carcinoma and Its
Predictable Clinicopathological. Ann
Surg Oncol. 2008;15:1375-82.
136.- Goh B, Chow P, Teo J, Wong J, Chan C,
Cheow P. Number of Nodules, Child-
Pugh Status, Margin Positivity, and
Microvascular Invasion, but Not Tumor
Size, Are Prognostic Factors of Survival
After Liver Resection for Multifocal
Hepatocellular Carcinoma. J Gastrointest
Surg. 2014;18:1477-85.
137.- Llovet J, Schwartz M, Mazzaferro V.
Resection and Liver Transplantation for
Hepatocellular Carcinoma. Semin Liver
Dis. 2005;25:181-200.
138.- Roayaie S, Blume I, Thung S, Guido
M, Fiel M, Hiotis S, et al. A System
of Classifying Microvascular Invasion
to Predict Outcome After Resection in
Patients with Hepatocellular Carcinoma
Sasan. Gastroenterology. 2009;137:850-
5.
139.- Lim KC, Chow PKH, Allen JC,
Chia GS, Lim M, Cheow PC, et al.
Microvascular Invasion Is a Better
Predictor of Tumor Recurrence and
Overall Survival Following Surgical
Resection for Hepatocellular Carcinoma
Compared to the Milan Criteria. Ann
Surg. 2011;254:108-13.
140.- Hsieh C, Wei C, Yin W, Chang C, Tsai
S, Wang L, et al. Vascular Invasion
Affects Survival in Early Hepatocellular
Carcinoma. Mol Clin Oncol.
2015;3:252-6.
141.- Shindoh J, Andreou A, Aloia TA,
Lauwers GY, Laurent A, Nagorney
DM, et al. Microvascular Invasion
Does Not Predict Long-Term Survival
in Hepatocellular Carcinoma up to 2
cm: Reappraisal of the Staging System
for Solitary Tumors Junichi. Ann Surg
Oncol. 2013;20:1223-9.
142.- Mazzaferro V, Llovet JM, Miceli R,
Bhoori S, Schiavo M, Mariani L, et
al. Predicting Survival After Liver
Transplantation in Patients with
Hepatocellular Carcinoma Beyond
the Milan Criteria: a Retrospective,
Exploratory Analysis. Lancet Oncol.
2009;10:35-43.
143.- Iguchi T, Shirabe K, Aishima S,
Wang H, Fujita N, Ninomiya M, et
al. New Pathologic Stratification
of Microvascular Invasion in
Hepatocellular Carcinoma: Predicting
Prognosis After Living-Donor Liver
Transplantation. Transplantation.
2015;99:1236-42.
144.- Rodríguez-Perálvarez M, Luong
T, Andreana L, Meyer T, Dhillon
A, Burroughs A. A Systematic
Review of Microvascular Invasion in
Hepatocellular Carcinoma: Diagnostic
and Prognostic Variability. Ann Surg
Oncol. 2013;20:325-39.
145.- Sapisochin G, Goldaracena N, Laurence
JM, Dib M, Barbas A, Ghanekar A, et
al. The Extended Toronto Criteria for
Liver Transplantation in Patients with
Hepatocellular Carcinoma: A Prospective
Validation Study. Hepatology.
2016;64:2077-88.
146.- Pinyol R, Nault JC, Quetglas IM,
Zucman-Rossi J, Llovet JM. Molecular
Profiling of Liver Tumors: Classification
and Clinical Translation for Decision
Making. Semin Liver Dis. 2014;34:363-
75.
147.- Borel F, Konstantinova P, Jansen PLM.
Diagnostic and Therapeutic Potential
of miRNA Signatures in Patients with
Hepatocellular Carcinoma. J Hepatol.
2012;56:1371-83.
148.- Ravindran S, Hancox S, Howlett D.
Liver Biopsy: Past, Present and Future.
Br J Hosp Med. 2016;77:90-5.
149.- Silva MA, Hegab B, Hyde C, Guo
B, Buckels JAC, Mirza DF. Needle
Track Seeding Following Biopsy of
Liver Lesions in the Diagnosis of
Hepatocellular Cancer: A Systematic
Review and Meta-Analysis. Gut.
2008;57:1592-6.
150.- Notarpaolo A, Layèse R, Magistri P,
Gambato M, Magini G, Miglioresi L,
et al. Validation of the AFP Model as a
Predictor of CHC Recurrence in Patients
with Viral Hepatitis-Related Cirrhosis
Who Had Received a Liver Transplant
for CHC. J Hepatol. 2016;66:552-9.
151.- Tangkijvanich; P, Anukulkarnkusol;
N, Suwangool; P, Lertmaharit; S,
Hanvivatvong; O, Kullavanijaya;
P, et al. Clinical Characteristics and
Prognosis of Hepatocellular Carcinoma:
Analysis Based on Serum Alpha-
Fetoprotein Levels. J Clin Gastroenterol.
2000;31:302-8.
152.- Hanazaki K, Kajikawa S, Koide N,
Adachi W, Amano J. Prognostic
Factors After Hepatic Resection
for Hepatocellular Carcinoma with
Hepatitis C Viral Infection: Univariate
and Multivariate Analysis. Am J
Gastroenterol. 2001;96:1243-50.
153.- Tyson G, Duan Z, Kramer J, Davila
J, Richardson P, El-Serag H. Level of
Alpha-Fetoprotein Predicts Mortality
among Patients with Hepatitis C-Related
Hepatocellular Carcinoma Gia. Clin
Gastroenterol Hepatol. 2011;9:989-94.
154.- Santambrogio R, Opocher E, Costa M,
Barabino M, Zuin M, Bertolini E, et
al. Hepatic Resection for “BCLC stage
A” Hepatocellular Carcinoma. The
Prognostic Role of Alpha-Fetoprotein.
Ann Surg Oncol. 2012;19:426-34.
155.- Yamamoto K, Imamura H, Matsuyama Y,
Hasegawa K, Yoshifumi B, Yasuhiko S,
et al. Significance of Alpha-Fetoprotein
and Des-γ-Carboxy Prothrombin in
Gastroenterol. latinoam 2019; Vol 30, Nº 2: 64-106